NIAGEN BIOSCIENCE, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $3.3M | $5.3M | — |
| FY2017 | — | $53.8M | — |
| FY2018 | — | $27.2M | $22.6M |
| FY2019 | — | $20.4M | $18.8M |
| FY2020 | — | $16.4M | $16.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $3.3M | $5.3M | — |
| FY2017 | — | $53.8M | — |
| FY2018 | — | $27.2M | $22.6M |
| FY2019 | — | $20.4M | $18.8M |
| FY2020 | — | $16.4M | $16.7M |